20 June 2024
Emcure Pharmaceuticals today received market regulator Securities and Exchange Board of India (SEBI) nod for its IPO launch. The company had filed its Draft Red Herring Prospectus with the market regulator in December 2023, the IPO comprises a fresh issuance of equity shares worth Rs 800cr and an offer of sale of 1.36 crore equity shares by promoters and existing shareholders, Proceeds of the fresh issue will be used towards payment of debt and for general corporate purposes.
Emcure Pharmaceuticals today received market regulator Securities and Exchange Board of India (SEBI) nod for its IPO launch. The company had filed its Draft Red Herring Prospectus with the market regulator in December 2023, the IPO comprises a fresh issuance of equity shares worth Rs 800cr and an offer of sale of 1.36 crore equity shares by promoters and existing shareholders, Proceeds of the fresh issue will be used towards payment of debt and for general corporate purposes.
Stay Connected, Stay Informed –
Don’t miss out on exclusive updates, market trends, and real-time investment opportunities. Be the first to know about the latest unlisted stocks, IPO announcements, and curated Fact Sheets, delivered straight to your WhatsApp.